Organization
Academic Trials Promoting Team
4 abstracts
Abstract
Clinico-molecular characteristics associated with outcomes in breast cancer patients treated with CDK4/6 inhibitors: Results from the AURORA Molecular Screening Initiative.Org: Université Libre de Bruxelles (ULB), Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (ULB), Brussels, Belgium, Breast International Group, Brussels, Belgium, Dana-Farber Cancer Institute, Vall d’Hebron Institute of Oncology (VHIO),
Abstract
Prostate-specific membrane antigen (PSMA) expression in patients with metastatic triple negative breast cancer: Initial results of the PRISMA study.Org: Academic Trials Promoting Team, Nuclear Medicine Department, Institut Jules Bordet and l’Université Libre de Bruxelles (U.L.B), Medical Oncology Department,
Abstract
Impact of young age at diagnosis on survival outcomes in patients with early breast cancer according to tumor subtype: Pooled analysis of 5 randomized clinical trials from the Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM).Org: Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, Genova, Italy, Genoa, IT, Italy, Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy, Istituto Nazionale Tumori Napoli IRCCS "Fondazione Pascale", Napoli, Italy, Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy, Department of Medicine (DAME), University of Udine; Dipartimento di Oncologia Medica, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Udine, Italy, Precision Medicine Unit in Senology Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy, IRCCS Sacro Cuore Don Calabria, Negrar Di Valpolicella, Italy, Clinical Oncology Department, IRCCS Ospedale Policlinico San Martino, Genoa, Italy, Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genoa, Genoa, Italy and Academic Trials Promoting Team, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium, IRCCS Azienda Ospedaliera Universitaria San Martino, Genova, Italy, Medical Research Council at UCL, London, United Kingdom, Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova and Medical Oncology Department, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy, Clinical Oncology Department, IRCCS Ospedale Policlinico San Martino Genoa, Genova, Italy, University of Genova, Genova, Italy, IRCCS Ospedale Policlinico San Martino, Istituto Nazionale Tumori Napoli IRCCS Fondazione Pascale, Napoli, Italy, University Federico II,
Abstract
Dissecting the prognostic role of baseline body mass index (BMI) in early breast cancer (BC): Individual patient-level analysis from five Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) randomized clinical trials (RCTs).Org: IRCCS Ospedale Policlinico San Martino, Unit of Clinical Epidemiology, Ospedale Policlinico San Martino, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, UOC Oncologia Medica,